Achilles Therapeutics (ACHL)
undefined
undefined%
At close: undefined
0.99
0.01%
After-hours Dec 13, 2024, 04:31 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -69.94M -71.18M -61.10M -33.20M -13.99M -6.89K
Depreciation & Amortization 4.71M 3.69M 3.29M 772.00K 302.00K 173.00
Stock-Based Compensation 6.36M 7.02M 6.32M 2.99M 719.00K 76.00
Other Working Capital 10.41M -7.86M -5.36M -2.25M -1.73M -846
Other Non-Cash Items 7.03K 6.88M -18.00K 1.18M -9.00K -114
Deferred Income Tax - - 159.00K - 14.00K -
Change in Working Capital 10.41M -5.96M -7.93M 3.00M -1.18M -846
Operating Cash Flow -48.45M -59.53M -59.28M -25.25M -14.14M -7.60K
Capital Expenditures -1.10M -7.51M -7.63M -11.85M -942.00K -258
Acquisitions - - - - - -
Purchase of Investments - - - - - -
Sales Maturities Of Investments - - - - - -
Other Investing Acitivies - -7.51M -7.63M - - -
Investing Cash Flow -1.10M -7.51M -7.63M -11.85M -942.00K -258
Debt Repayment - - - - - -
Common Stock Repurchased - - - - - -
Dividend Paid - - - - - -
Other Financial Acitivies 34.88 - 160.75M 113.70M 93.23M 13.51K
Financial Cash Flow 9.00K 1K 160.75K 113.70M 93.62M 13.51K
Net Cash Flow -41.80M -92.98M 88.50M 80.25M 86.91M 5.70K
Free Cash Flow -49.55M -67.05M -66.92M -37.10M -15.08M -7.86K